Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Multiple Comorbidities

被引:0
作者
Glaspole, I. [1 ,2 ]
Bonella, F. [3 ]
Bargagli, E. [4 ]
Glassberg, M. K. [5 ]
Caro, F. [6 ]
Stansen, W. [7 ]
Quaresma, M. [8 ]
Orsatti, L. [8 ]
Bendstrup, E. [9 ]
机构
[1] Alfred Hlth, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia
[2] Monash Univ, Dept Med, Melbourne, Vic, Australia
[3] Duisburg Essen Univ, Interstitial & Rare Lung Dis Unit, Ruhrlandklin, Univ Hosp, Essen, Germany
[4] Siena Univ Hosp, Sect Resp Dis & Lung Transplantat, Dept Clin Med & Neurosci, Siena, Italy
[5] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[6] Maria Ferrer Hosp, Buenos Aires, DF, Argentina
[7] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
[8] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[9] Aarhus Univ Hosp, Dept Resp Dis & Allergy, Aarhus, Denmark
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A4549
引用
收藏
页数:2
相关论文
共 50 条
[21]   SHORT-TERM SAFETY OF NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS [J].
Saji, J. ;
Okamoto, M. ;
Matsuzawa, S. ;
Oyama, B. ;
Onoe, R. ;
Kakinuma, K. ;
Azagami, S. ;
Muraoka, H. ;
Morikawa, K. ;
Takemura, M. ;
Inoue, T. ;
Kida, H. ;
Furuya, N. ;
Handa, H. ;
Nishine, H. ;
Ishida, A. ;
Inoue, T. ;
Miyazawa, T. ;
Mineshita, M. .
RESPIROLOGY, 2016, 21 :36-36
[22]   Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Global Pharmacovigilance Data [J].
Lasky, Joseph A. ;
Criner, Gerard J. ;
Lazarus, Howard M. ;
Kohlbrenner, Veronika ;
Bender, Shaun ;
Richeldi, Luca .
ADVANCES IN THERAPY, 2020, 37 (10) :4209-4219
[23]   Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Global Pharmacovigilance Data [J].
Joseph A. Lasky ;
Gerard J. Criner ;
Howard M. Lazarus ;
Veronika Kohlbrenner ;
Shaun Bender ;
Luca Richeldi .
Advances in Therapy, 2020, 37 :4209-4219
[24]   Histologic factors associated with nintedanib efficacy in patients with idiopathic pulmonary fibrosis [J].
Nemoto, Masahiro ;
Zaizen, Yoshiaki ;
Kataoka, Kensuke ;
Kuroda, Kishio ;
Tabata, Kazuhiro ;
Bychkov, Andrey ;
Sumikawa, Hiromitsu ;
Johkoh, Takeshi ;
Aoshima, Masahiro ;
Kondoh, Yasuhiro ;
Fukuoka, Junya .
PLOS ONE, 2021, 16 (01)
[25]   The safety and tolerability of nintedanib in the treatment of idiopathic pulmonary fibrosis [J].
Cottin, Vincent .
EXPERT OPINION ON DRUG SAFETY, 2017, 16 (07) :857-865
[26]   Broad Therapeutic Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis [J].
Wells, Athol U. ;
Rosas, Ivan O. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193 (02) :112-113
[27]   Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis [J].
Ogura, Takashi ;
Taniguchi, Hiroyuki ;
Azuma, Arata ;
Inoue, Yoshikazu ;
Kondoh, Yasuhiro ;
Hasegawa, Yoshinori ;
Bando, Masashi ;
Abe, Shinji ;
Mochizuki, Yoshiro ;
Chida, Kingo ;
Klueglich, Matthias ;
Fujimoto, Tsuyoshi ;
Okazaki, Kotaro ;
Tadayasu, Yusuke ;
Sakamoto, Wataru ;
Sugiyama, Yukihiko .
EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (05) :1382-1392
[28]   Effect of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis [J].
Kawada, Tomoyuki .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (09) :1274-+
[29]   Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis (vol 370, pg 2071, 2014) [J].
Richeldi, Luca ;
du Bois, Roland M. ;
Raghu, Ganesh .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (08) :782-782
[30]   Real-World Safety and Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis [J].
Azuma, Arata ;
Ogura, Takashi ;
Inoue, Yoshikazu ;
Kondoh, Yasuhiro ;
Homma, Sakae ;
Tanaka, Katsumi ;
Ochiai, Kaori ;
Muraishi, Kenya ;
Sugiyama, Yukihiko ;
Nukiwa, Toshihiro .
EUROPEAN RESPIRATORY JOURNAL, 2023, 62